Skip to content
The Longevity Archive
Petrelintide in all countries

Legal status · United States

Is Petrelintide legal in the United States?

InvestigationalMetabolicEvidence: Moderate

No. Petrelintide is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Petrelintide in the United States at a glance

ClassificationInvestigational, not approved
FDA approval statusInvestigational (Phase 3 planned to start in the second half of 2026)
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Petrelintide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.

What this means

  • 01

    Petrelintide is being studied in registered clinical trials but has not received FDA marketing approval in the United States.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Petrelintide is

A once-weekly amylin analogue from Zealand and Roche being developed as a potentially better-tolerated obesity treatment, with positive Phase 2 results.

Petrelintide is a long-acting amylin analogue developed by Zealand Pharma and Roche as a stand-alone obesity therapy, on the idea that amylin-based drugs may be better tolerated than GLP-1 agonists. 7% weight loss at 42 weeks, and it is planned to move to Phase 3 in the second half of 2026.

Mechanism: Agonizes amylin receptors to promote satiety and slow gastric emptying, used as a single-agent weight-loss approach.

Regulatory history: Investigational (Phase 3 planned to start in the second half of 2026)

How FDA treats this kind of product

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Petrelintide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Petrelintide in other countries

Frequently asked questions

Is Petrelintide legal in the United States?

No. Petrelintide is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Petrelintide in the United States?

No approved product exists to buy. In the United States Petrelintide is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Petrelintide FDA approved?

No. FDA status: Investigational (Phase 3 planned to start in the second half of 2026). Current US classification: "Investigational, not approved". Evidence level: Moderate.

Related compounds in the United States

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Petrelintide live on its compound profile.

Petrelintide profile

This page is general information about the regulatory status of Petrelintide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.